| Inhibition of glioblastoma cell proliferation, invasion, and mechanism of action of a novel hydroxamic acid hybrid molecule I Zhang, M Beus, U Stochaj, PU Le, B Zorc, Z Rajić, K Petrecca, ... Cell death discovery 4 (1), 41, 2018 | 39 | 2018 |
| Mass spectrometry imaging in zebrafish larvae for assessing drug safety and metabolism M Asslan, N Lauzon, M Beus, D Maysinger, S Rousseau Analytical and Bioanalytical Chemistry 413 (20), 5135-5146, 2021 | 19 | 2021 |
| Primaquine derivatives: Modifications of the terminal amino group B Zorc, I Perković, K Pavić, Z Rajić, M Beus European journal of medicinal chemistry 182, 111640, 2019 | 15 | 2019 |
| Synthesis and biological evaluation of harmirins, novel harmine–coumarin hybrids as potential anticancer agents K Pavić, M Beus, G Poje, L Uzelac, M Kralj, Z Rajić Molecules 26 (21), 6490, 2021 | 14 | 2021 |
| Primaquine and chloroquine fumardiamides as promising antiplasmodial agents M Beus, D Fontinha, J Held, Z Rajić, L Uzelac, M Kralj, M Prudêncio, ... Molecules 24 (15), 2812, 2019 | 14 | 2019 |
| Chloroquine fumardiamides as novel quorum sensing inhibitors M Beus, K Savijoki, JZ Patel, J Yli-Kauhaluoma, A Fallarero, B Zorc Bioorganic & medicinal chemistry letters 30 (16), 127336, 2020 | 13 | 2020 |
| Asymmetric primaquine and halogenaniline fumardiamides as novel biologically active Michael acceptors Z Rajić, M Beus, H Michnová, J Vlainić, L Persoons, I Kosalec, J Jampílek, ... Molecules 23 (7), 1724, 2018 | 12 | 2018 |
| Itaconic acid hybrids as potential anticancer agents I Perković, M Beus, D Schols, L Persoons, B Zorc Molecular diversity, 1-14, 2022 | 10 | 2022 |
| SAHAquines, novel hybrids based on SAHA and primaquine motifs, as potential cytostatic and antiplasmodial agents M Beus, Z Rajić, D Maysinger, Z Mlinarić, M Antunović, I Marijanović, ... ChemistryOpen 7 (8), 624-638, 2018 | 9 | 2018 |
| Synthesis and antiplasmodial evaluation of novel mefloquine-based fumardiamides M Beus, D Fonthina, J Held, Z Rajić, M Prudencio, B Zorc Acta pharmaceutica 69 (2), 233-248, 2019 | 8 | 2019 |
| Anthranilamides with quinoline and β-carboline scaffolds: Design, synthesis, and biological activity M Beus, L Persoons, D Daelemans, D Schols, K Savijoki, P Varmanen, ... Molecular diversity, 1-18, 2022 | 7 | 2022 |
| Particle surface functionalization affects mechanism of endocytosis and adverse effects of silver nanoparticles in mammalian kidney cells M Beus, IM Pongrac, I Capjak, K Ilić, E Vrček, M Ćurlin, M Milić, ... Journal of Applied Toxicology 43 (3), 416-430, 2023 | 4 | 2023 |
| Synthesis and biological evaluation of new quinoline and anthranilic acid derivatives as potential quorum sensing inhibitors I Perković, T Poljak, K Savijoki, P Varmanen, G Maravić-Vlahoviček, ... Molecules 28 (15), 5866, 2023 | 3 | 2023 |
| Selenium nanoparticles as potential drug-delivery systems for the treatment of Parkinson’s disease N Kalčec, N Peranić, I Mamić, M Beus, CR Hall, TA Smith, MA Sani, ... ACS applied nano materials 6 (19), 17581-17592, 2023 | 2 | 2023 |
| Hazard assessment of nanomaterials using in vitro toxicity assays: Guidance on potential assay interferences and mitigating actions to avoid biased results N El Yamani, E Rundén-Pran, J Varet, M Beus, M Dusinska, V Fessard, ... Nano today 55, 102215, 2024 | | 2024 |
| Novel PLGA-based nanoformulation decreases doxorubicin-induced cardiotoxicity N Drinković, M Beus, R Barbir, Ž Debeljak, BT Lovaković, N Kalčec, ... Nanoscale 16 (19), 9412-9425, 2024 | | 2024 |
| Cellular model of Parkinson's disease for safety testing of goldbased nanodelivery system I Mamić, M Beus, N Peranić, N Kalčec, P Turčić, IV Vrček Arhiv Za Higijenu Rada i Toksikologiju 73 (2), A14-A14, 2022 | | 2022 |
| Dizajniranje, sinteza i citostatsko djelovanje sahakina M Beus University of Zagreb. Faculty of Pharmacy and Biochemistry. Department of …, 2020 | | 2020 |
| Ljekoviti laboratorij G Poje, M Marinović, M Beus | | 2019 |
| Sinteza pirazinskih analoga antitumorskog lijeka sorafeniba M Beus, T Ubrekić, J Vidović | | 2014 |
